Company: NCEL
Filing Date: 2025-05-05
Form Type: 6-K
Source: 0001213900-25-039691
Chunk: 1

Company: NewcelX Ltd.
Filing Date: 2025-05-05
Form: 6-K
Chunk 1
---
 forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described
in the forward-looking statements: risks related to the companies’ ability to complete the merger on the proposed terms and schedule,
including risks and uncertainties related to the satisfaction of the closing conditions related to the merger agreement and risks and
uncertainties related to the failure to timely, or at all, obtain shareholder approvals for the transaction; and unexpected costs, charges
or expenses resulting from the transaction and potential adverse reactions or changes to business relationships resulting from the announcement
or completion of the proposed merger. Except as otherwise required by law, neither Kadimastem nor the Company undertakes any obligation
to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect
the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained
under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the year ended December 31, 2023, filed
with the Securities and Exchange Commission (“SEC”), which is available on the SEC’s website, www.sec.gov, and in subsequent
filings made by the Company with the SEC.

No Offer or Solicitation

This
communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities,
or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities
shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

<div align='center'>1</div>

Additional Information about the Transaction and Where to Find It

In
connection with the proposed transaction, the Company filed a registration statement on Form F-4 on December 30, 2023, including a proxy
statement/prospectus, with the SEC (the “F-4 Registration Statement”), and subsequent Amendments to the F-4 Registration Statement
on March 3, 2025 and March 31, 2025. The Company may also file other relevant documents regarding the proposed transaction with the SEC,
including an amendment to the F-4 Registration Statement. This document is not a substitute for the proxy statement/prospectus or any
other document that the Company